Status: Not yet recruiting
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
This is an Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Combined With Tegafur Gimeracil Oteracil in the Third-line Treatment of Patients With Advanced Metastatic CRC
Participants needed: 52
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Guangzhou University of Traditional Chinese MedicineUpdated: Apr 29, 2024Locations: 1
Eligibility criteria
≥ 18 and ≤ 75 years of age; [+9]
Pregnant or lactating women; [+23]